Summit Presents In Vivo Proof of Concept Data for New Mechanism Antibiotics Targeting Enterobacteriaceae in Oral Session at ECCMID 2019

Ads

You May Also Like

Medivir proceeds with a separation of the company’s operations

Stockholm, Sweden — Medivir AB (Nasdaq Stockholm: MVIR) today announces that the Board of ...

Immunomedics to Present at Cowen and Company 37th Annual Health Care Conference

MORRIS PLAINS, N.J., Feb. 28, 2017 (GLOBE NEWSWIRE) -- Immunomedics, Inc., (NASDAQ:IMMU) (“Immunomedics” or ...